Back to search
FDAFDA · Food and drugs·Recall number D-1165-2022

SnoreStop NasoSpray, 0.3 FL OZ (9 mL), Green Pharmaceuticals Inc. Camarillo, CA 93012, NDC 61152-199-99, UPC 7 69682 29101 3

Published July 6, 2022 · Recall initiated: June 9, 2022

Summary

FDA records drug Class I recall D-1165-2022, published July 6, 2022 and initiated June 9, 2022. Recalling firm: Green Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 1074 spray bottles; Lot: Lot #: 2373/21222. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Green Pharmaceuticals, Inc.
Distributor
Nationwide within the United States
Lot
Lot #: 2373/21222
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was SnoreStop NasoSpray, 0.3 FL OZ (9 mL), Green Pharmaceuticals Inc. Camarillo, CA 93012, NDC 61152-199-99, UPC 7 69682 29101 3 recalled?

Yes. FDA published recall D-1165-2022 on July 6, 2022. Reported hazard: Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit